Taiwan Liposome Company   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Taipei City Taiwan (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
1999
NCT00002019
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Liposome | Taiwan Liposome Company | Taiwan Liposome Company, Ltd.